BBOT vs CDT (BridgeBio Oncology Therapeutics Inc. vs CDT Equity Inc.)
Showing Closing Date Range from Oct 4 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
US Market Trading Session Active
Active trading session is live as of 10:41 AM ET. Prices update dynamically and reflect the latest trade records across major US exchanges. Official closing prices settle after 4:00 PM ET.
BBOT leads by +19.53% Alpha Spread Today
BBOT is trading at -1.27% while CDT is at -20.80% .
Started At
Official opening auction price
Last Recorded Trade Price
Last recorded trade as of 10:41 AM ET
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | BBOT | CDT | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -1.27% | -20.80% | BBOT +19.53% |
| Net Dollar Move | $-0.05 | $-0.26 | BBOT higher move |
| Open Price | $3.97 | $1.28 | Gap: -3.17% vs 2.40% |
| Day High | $4.05 | $1.28 | Session peaks |
| Day Low | $3.89 | $0.95 | Session troughs |
| Intraday Spread | $0.16 | $0.33 | High/Low spread |
| Share Volume | 485.8K | 978.4K | CDT more active |
| Est. Dollar Volume | $1.89M | $968.6K | BBOT higher liquidity |
Explore BBOT vs CDT Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.